# Janux Therapeutics, Inc.: Form 8-K, filed Jun 28, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: 8-K
- Filed: 2024-06-28
- Accepted by EDGAR: Jun 28, 2024, 16:12 ET
- Period: 2024-06-26
- Accession: 0000950170-24-079059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/janx-20240626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/janx-20240626.htm

Filed Jun 28, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-079059. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.